Cargando…
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain. Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an...
Ejemplares similares
-
Identification and Preclinical Evaluation of the Bicyclic
Pyrimidine γ-Secretase Modulator BMS-932481
por: Boy, Kenneth M., et al.
Publicado: (2019) -
The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers
por: Soares, Holly D., et al.
Publicado: (2016) -
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
por: Toyn, Jeremy H, et al.
Publicado: (2014) -
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects
por: Toyn, Jeremy H., et al.
Publicado: (2016) -
Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)